Is Cardlytics Stock a Good Investment?
Cardlytics Investment Advice | CDLX |
- Examine Cardlytics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Cardlytics' leadership team and their track record. Good management can help Cardlytics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Advertising space and any emerging trends that could impact Cardlytics' business and its evolving consumer preferences.
- Compare Cardlytics' performance and market position to its competitors. Analyze how Cardlytics is positioned in terms of product offerings, innovation, and market share.
- Check if Cardlytics pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Cardlytics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Cardlytics stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Cardlytics is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Cardlytics Stock
Researching Cardlytics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 62.0% of the company shares are held by institutions such as insurance companies. The book value of Cardlytics was currently reported as 1.38. The company recorded a loss per share of 6.4. Cardlytics had not issued any dividends in recent years.
To determine if Cardlytics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cardlytics' research are outlined below:
| Cardlytics had very high historical volatility over the last 90 days | |
| Cardlytics has high likelihood to experience some financial distress in the next 2 years | |
| Cardlytics currently holds 266.11 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 309.2 M. Net Loss for the year was (134.7 M) with profit before overhead, payroll, taxes, and interest of 115.42 M. | |
| Cardlytics currently holds about 157.04 M in cash with (185 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 62.0% of Cardlytics shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Cardlytics Reports Q3 Loss, Tops Revenue Estimates - MSN |
Cardlytics Quarterly Accounts Payable |
|
Cardlytics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cardlytics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cardlytics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Cardlytics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Cardlytics' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-07 | 2024-06-30 | -0.13 | -0.15 | -0.02 | 15 | ||
2024-05-08 | 2024-03-31 | -0.11 | -0.09 | 0.02 | 18 | ||
2024-03-14 | 2023-12-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2023-11-08 | 2023-09-30 | -0.01 | 0.01 | 0.02 | 200 | ||
2021-03-01 | 2020-12-31 | -0.03 | -0.05 | -0.02 | 66 | ||
2020-05-11 | 2020-03-31 | -0.21 | -0.26 | -0.05 | 23 | ||
2022-11-01 | 2022-09-30 | -0.57 | -0.5 | 0.07 | 12 | ||
2018-08-14 | 2018-06-30 | -0.52 | -0.59 | -0.07 | 13 |
Know Cardlytics' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cardlytics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cardlytics backward and forwards among themselves. Cardlytics' institutional investor refers to the entity that pools money to purchase Cardlytics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2024-06-30 | 665.5 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 638 K | Lpl Financial Corp | 2024-06-30 | 591.2 K | Baillie Gifford & Co Limited. | 2024-09-30 | 567.4 K | Davidson Kempner Capital Management Lp | 2024-06-30 | 550 K | General Equity Holdings Lp | 2024-09-30 | 533.5 K | Renaissance Technologies Corp | 2024-09-30 | 410.9 K | Pb Investment Partners, L.p. | 2024-09-30 | 397.1 K | Charles Schwab Investment Management Inc | 2024-09-30 | 390.3 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 4.3 M | Blackrock Inc | 2024-06-30 | 3.2 M |
Cardlytics' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 186.52 M.Market Cap |
|
Cardlytics' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.57) | (0.60) | |
| Return On Capital Employed | (0.34) | (0.35) | |
| Return On Assets | (0.23) | (0.25) | |
| Return On Equity | (1.00) | (1.05) |
Determining Cardlytics' profitability involves analyzing its financial statements and using various financial metrics to determine if Cardlytics is a good buy. For example, gross profit margin measures Cardlytics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cardlytics' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Cardlytics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cardlytics. Check Cardlytics' Beneish M Score to see the likelihood of Cardlytics' management manipulating its earnings.
Evaluate Cardlytics' management efficiency
Cardlytics has return on total asset (ROA) of (0.0762) % which means that it has lost $0.0762 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8612) %, meaning that it created substantial loss on money invested by shareholders. Cardlytics' management efficiency ratios could be used to measure how well Cardlytics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.6 in 2024. Return On Capital Employed is likely to drop to -0.35 in 2024. At this time, Cardlytics' Net Tangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to rise to 0.62 in 2024, whereas Total Assets are likely to drop slightly above 440 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.69 | 3.88 | |
| Tangible Book Value Per Share | (5.54) | (5.81) | |
| Enterprise Value Over EBITDA | (5.15) | (5.41) | |
| Price Book Value Ratio | 2.49 | 3.76 | |
| Enterprise Value Multiple | (5.15) | (5.41) | |
| Price Fair Value | 2.49 | 3.76 | |
| Enterprise Value | 510.3 M | 484.8 M |
The decision-making processes within Cardlytics are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 1.618 |
Basic technical analysis of Cardlytics Stock
As of the 22nd of November, Cardlytics shows the Mean Deviation of 3.81, downside deviation of 5.71, and Risk Adjusted Performance of 0.0105. Cardlytics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cardlytics' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardlytics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardlytics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardlytics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cardlytics' Outstanding Corporate Bonds
Cardlytics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cardlytics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cardlytics bonds can be classified according to their maturity, which is the date when Cardlytics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| US14162VAB27 Corp BondUS14162VAB27 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Cardlytics' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Cardlytics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0105 | |||
| Market Risk Adjusted Performance | 0.0111 | |||
| Mean Deviation | 3.81 | |||
| Semi Deviation | 5.62 | |||
| Downside Deviation | 5.71 | |||
| Coefficient Of Variation | 38828.97 | |||
| Standard Deviation | 5.32 | |||
| Variance | 28.31 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0011 | |||
| Maximum Drawdown | 33.81 | |||
| Value At Risk | (7.63) | |||
| Potential Upside | 9.42 | |||
| Downside Variance | 32.57 | |||
| Semi Variance | 31.54 | |||
| Expected Short fall | (3.82) | |||
| Skewness | (0.71) | |||
| Kurtosis | 3.66 |
| Risk Adjusted Performance | 0.0105 | |||
| Market Risk Adjusted Performance | 0.0111 | |||
| Mean Deviation | 3.81 | |||
| Semi Deviation | 5.62 | |||
| Downside Deviation | 5.71 | |||
| Coefficient Of Variation | 38828.97 | |||
| Standard Deviation | 5.32 | |||
| Variance | 28.31 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0011 | |||
| Maximum Drawdown | 33.81 | |||
| Value At Risk | (7.63) | |||
| Potential Upside | 9.42 | |||
| Downside Variance | 32.57 | |||
| Semi Variance | 31.54 | |||
| Expected Short fall | (3.82) | |||
| Skewness | (0.71) | |||
| Kurtosis | 3.66 |
Consider Cardlytics' intraday indicators
Cardlytics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cardlytics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cardlytics Corporate Filings
F4 | 15th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 21st of August 2024 An amendment to a previously filed Form 8-K | ViewVerify |
Cardlytics Stock media impact
Far too much social signal, news, headlines, and media speculation about Cardlytics that are available to investors today. That information is available publicly through Cardlytics media outlets and privately through word of mouth or via Cardlytics internal channels. However, regardless of the origin, that massive amount of Cardlytics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cardlytics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardlytics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardlytics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardlytics alpha.
Cardlytics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Cardlytics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cardlytics Corporate Management
| Evelyne Forester | Chief Officer | Profile | |
| Carson Napps | Chief Officer | Profile | |
| Jose Singer | Chief Officer | Profile | |
| Alexis DeSieno | Chief Officer | Profile | |
| Karim Temsamani | CEO Director | Profile | |
| James Hart | VP People | Profile |
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.